Concepedia

Greg A. Erickson

GA

Statistics

Publications

4

Citations

78

H-Index

4

Active since

2007

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Greg A. Erickson is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, synthetic medicinal chemistry, and chemistry.

Publications per year

2007–2018

4

Publications

4

Convergent Synthesis of the NS5B Inhibitor GSK8175 Enabled by Transition Metal Catalysis

Kenneth L. Arrington, Gregg A. Barcan, Nicholas A. Calandra et al. · The Journal of Organic Chemistry · 2018 · 37 citations

, , +14

Synthesis of Lapatinib via direct regioselective arylation of furfural

Greg A. Erickson, Jiasheng Guo, Mike McClure et al. · Tetrahedron Letters · 2014 · 17 citations

, , +5

A Scaleable Synthesis of Methyl 3-Amino-5-(4-fluorobenzyl)-2-pyridinecarboxylate

Eric E. Boros, Svetlana A. Burova, Greg A. Erickson et al. · Organic Process Research & Development · 2007 · 14 citations

, , +9

Development of Large-Scale Routes to Potent GPR119 Receptor Agonists

Richard T. Matsuoka, Eric E. Boros, Andrew D. Brown et al. · Organic Process Research & Development · 2016 · 10 citations

, , +11

1–4 of 4